Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 35 results for "lacosamide"

Human medicines European public assessment report (EPAR): Vi...

This is a summary of the European public assessment report (EPAR) for Vimpat. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ... European Medicines Agency, 2 days ago

UCB seeks marketing authorization for lacosamide in Japan to treat epilepsy

Daiichi Sankyo Company Limited and UCB Japan Company Ltd, a division of UCB group, announced that UCB Japan has applied for marketing authorization for lacosamide in Japan as adjunctive therapy in the treatment of partial onset seizures with or ...
 PharmaBiz1 month ago Daiichi Sankyo gets EU approval for Lixiana; lacosamide filed in Japan  Pharma Letter1 month ago Application for Marketing Authorization for Lacosamide (Generic Name) in Japan for the Treatment of Epilepsy  Noodls1 month ago DAIICHI SANKYO : Application for Marketing Authorization for Lacosamide (Generic Name) in Japan for the Treatment of Epilepsy  4 Traders1 month ago

New and Generic Drug Approvals: Lacosamide

Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to
 U.S. Food and Drug Administration2 weeks ago

Claim Term Is Construed In Lacosamide ANDA Case

UCB, Inc. et al. v. Accord Healthcare, Inc., et al. , C.A. No. 13-1206-LPS, May 14, 2015 Stark, C.J. Claim construction ruling issues on one term from the patent-in-suit. Multimedia technology tutorials had been submitted, and a claim ...
 JD Supra1 month ago
India Infoline

Alembic Pharma gains on buzz of getting USFDA nod

Media reports said that the company has got tentative US FDA nod for Epilepsy drug Lacosamide.
 India Infoline2 months ago

Directrices publicadas en Epilepsy and Behaviour para el cambio de oxcarbazepina o carbamazepina a acetato de eslicarbazepina en determinadas situaciones clínicas

/PRNewswire/ -- Las n uevas directrices para el tratamiento de la epilepsia , definidas por un grupo asesor de expertos, proporcionan recomendaciones para el cambio a acetato de eslicarbazepina COMUNICADO DE PRENSA SOLO PARA MEDIOS DE LA ...
 PR Newswire4 weeks ago

Pubblicate su Epilepsy and Behaviour le nuove raccomandazioni relative al passaggio dei pazienti da oxcarbazepina/carbamazepina a eslicarbazepina acetato in alcuni quadri clinici

/PRNewswire/ -- Nuove raccomandazioni definite da un gruppo di esperti per il passaggio a eslicarbazepina acetato COMUNICATO STAMPA DESTINATO ESCLUSIVAMENTE AI MEDIA DELL'UE: NON DESTINATO AI GIORNALISTI DI SVIZZERA/ AUSTRIA /STATI UNITI ...
 PR Newswire1 month ago

June 29, 2015June 30, 2015

/PRNewswire/ — PRESS RELEASE FOR EU MEDIA ONLY: NOT FOR SWISS/AUSTRIAN/U.S. JOURNALISTS New epilepsy treatment guidance , as defined by an advisory panel of experts, provides recommendations for transition to eslicarbazepine actate New ...
 Prbox.com1 month ago Guidance on the Transition of Patients from Oxcarbazepine or Carbamazepine to Eslicarbazepine Acetate in Certain Clinical Situations Now Published in Epilepsy and Behaviour  Individual.com1 month ago

Recommandations pour passer de l'oxcarbazépine ou de la carbamazépine a l'acétate d'eslicarbazépine dans certaines situations cliniques, publiees dans Epilepsy and Behaviour

/PRNewswire/ -- Un groupe consultatif d ' experts, publie des recommandations pour passer à l ' acétate d ' eslicarbazépine dans le traitement des crises d ' épilepsie partielles chez certains patients COMMUNIQUÉ DE PRESSE DESTINÉ AUX MÉDIAS ...
 BioMedReports1 month ago Recommandations pour passer de loxcarbazépine ou de la carbamazépine a lacétate deslicarbazépine dans certaines situations cliniques, publiees…  Gnom.es1 month ago

Leitfaden zur Umstellung von Patienten von Oxcarbazepin oder Carbamazepin auf Eslicarbazepinacetat in bestimmten klinischen Situationen jetzt in Epilepsy and Behavior veröffentlicht

/PRNewswire/ -- N eue r Leitfaden eines Expertengremiums gibt Empfehlungen für die Umst ellung auf Eslicarbazepinacetat PRESSEMITTEILUNG NUR FÜR EU-MEDIEN: NICHT FÜR JOURNALISTEN AUS DER SCHWEIZ/ÖSTERREICH/DEN USA Ein neuer ...
 PR Newswire1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - lacosamide
Get updated on latest news & your favorite topics right in your inbox!
More     Less